Kingsview Wealth Management LLC Makes New $2.55 Million Investment in Astera Labs, Inc. $ALAB

by · The Markets Daily

Kingsview Wealth Management LLC acquired a new position in shares of Astera Labs, Inc. (NASDAQ:ALAB – Free Report) in the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 5,285 shares of the company’s stock, valued at approximately $2,553,000.

A number of other hedge funds have also made changes to their positions in ALAB. Keating Financial Advisory Services Inc. acquired a new stake in shares of Astera Labs during the 2nd quarter worth about $25,000. Transamerica Financial Advisors LLC purchased a new position in Astera Labs in the second quarter valued at approximately $35,000. Johnson Financial Group Inc. purchased a new position in Astera Labs in the second quarter valued at approximately $43,000. Bell Investment Advisors Inc purchased a new position in Astera Labs in the second quarter valued at approximately $43,000. Finally, Reflection Asset Management acquired a new stake in Astera Labs during the fourth quarter worth approximately $25,000. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Astera Labs Trading Down 4.8%

ALAB stock opened at $289.47 on Friday. The company has a market capitalization of $50.22 billion, a P/E ratio of 143.30 and a beta of 3.84. The business has a 50 day simple moving average of $342.38 and a 200-day simple moving average of $249.65. Astera Labs, Inc. has a twelve month low of $97.89 and a twelve month high of $499.48.

Astera Labs (NASDAQ:ALAB – Get Free Report) last announced its earnings results on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, beating analysts’ consensus estimates of $0.69 by $0.11. The business had revenue of $392.40 million for the quarter, compared to analysts’ expectations of $360.85 million. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The company’s quarterly revenue was up 104.5% on a year-over-year basis. During the same period in the previous year, the company posted $0.44 EPS. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. Research analysts predict that Astera Labs, Inc. will post 2.7 EPS for the current fiscal year.

Insiders Place Their Bets

In other news, CEO Jitendra Mohan sold 90,630 shares of the stock in a transaction dated Monday, August 17th. The shares were sold at an average price of $340.35, for a total transaction of $30,845,920.50. Following the completion of the sale, the chief executive officer owned 1,266,665 shares in the company, valued at approximately $431,109,432.75. This represents a 6.68% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Manuel Alba sold 136,974 shares of the business’s stock in a transaction dated Wednesday, July 1st. The shares were sold at an average price of $442.01, for a total value of $60,543,877.74. Following the completion of the transaction, the director owned 1,287,524 shares in the company, valued at $569,098,483.24. This trade represents a 9.62% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 419,244 shares of company stock valued at $163,135,169. 10.40% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

Several analysts have recently weighed in on ALAB shares. Citigroup restated a “buy” rating on shares of Astera Labs in a research report on Wednesday, July 29th. Bank of America increased their target price on shares of Astera Labs from $240.00 to $450.00 and gave the company a “neutral” rating in a research report on Tuesday, June 23rd. Zacks Research raised shares of Astera Labs from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, August 11th. TD Cowen decreased their price objective on shares of Astera Labs from $425.00 to $375.00 and set a “hold” rating for the company in a research note on Wednesday, August 5th. Finally, Roth Capital reaffirmed a “buy” rating and set a $450.00 price objective on shares of Astera Labs in a report on Wednesday, August 5th. One equities research analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and eight have given a Hold rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $340.53.

View Our Latest Analysis on ALAB

Astera Labs Profile

(Free Report)

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.

Featured Articles

Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB – Free Report).